Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NPCE - NeuroPace Inc

IEX Last Trade
10.635
-0.105   -0.987%

Share volume: 1,049
Last Updated: Fri 27 Dec 2024 05:29:30 PM CET
Surgical and Medical Instrument Manufacturing : -0.45%

PREVIOUS CLOSE
CHG
CHG%
$10.74
-0.11
-0.98%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
10%
Profitability 0%
Dept financing 25%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.62%
1 Month
9.22%
3 Months
65.77%
6 Months
62.63%
1 Year
12.53%
2 Year
731.34%
Key data
Stock price
$10.64
P/E Ratio 
-7.73
DAY RANGE
$10.56 - $11.34
EPS 
-$1.09
52 WEEK RANGE
$6.06 - $18.15
52 WEEK CHANGE
$11.40
MARKET CAP 
231.240 M
YIELD 
N/A
SHARES OUTSTANDING 
29.197 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
BETA 
1.27
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$83,397
AVERAGE 30 VOLUME 
$70,657
Company detail
CEO: Michael Favet
Region: US
Website: www.neuropace.com
Employees: 170
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

NeuroPace, Inc. develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Recent news